SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCaledonia Regulatory News (CLDN)

Share Price Information for Caledonia (CLDN)

Share Price is delayed by 15 minutes
Get Live Data
355.50    5.50 (1.57%)
Bid:
354.00
Ask:
358.00
Spread: 4.00 (1.13%)
Market Cap: £1.82b
CLDN Live PriceLast checked at - London Stock Exchange

Intraday Caledonia Share Chart

Director/PDMR Shareholding

21 Sep 2020 15:02

RNS Number : 6230Z
Caledonia Investments PLC
21 September 2020
Β 

Caledonia Investments plc

Β 

Notification of transactions of persons discharging managerial responsibilities ("PDMR") or persons closely associated with them ("PCA")

Β 

Caledonia Investments plc ("Caledonia" or the "Company") has been notified pursuant to the requirements of the Market Abuse Regulation of the following transactions in its ordinary shares of 5p ("Shares") involving persons closely associated with one of its directors, Jamie Cayzer-Colvin.

Β 

On 16 September 2020:

Β 

(i) A family trust in which Mr Cayzer-Colvin holds a beneficial interest sold 1,000 Shares, representing 0.002% of the Company's total issued ordinary share capital, to a registered charity of which Mr Cayzer-Colvin is a trustee. All Shares were sold at 2562.5p per share. The transaction decreased Mr Cayzer-Colvin's beneficial holdings and increased his non-beneficial holdings in the Company. The transaction took place in London.

Β 

(ii) Mr Cayzer-Colvin was appointed as a trustee of a family trust. The trust holds 16,237 Shares in the Company, representing 0.029% of the Company's total issued ordinary share capital. Mr Cayzer-Colvin's appointment increases his non-beneficial holdings in the Company.

Β 

(iii) A family trust in which Mr Cayzer-Colvin holds a beneficial interest appropriated 3,529 Shares in the Company, representing 0.006% of the Company's total issued share capital, between two of its funds. All Shares were appropriated at 2550p per share. There was no change to Mr Cayzer-Colvin's beneficial or non-beneficial holdings in the Company as a result of the transaction. The transaction was conducted off-market and in London.

Β 

Mr Cayzer-Colvin's total interests in Shares following the above transactions are as follows:

Β 

Beneficial - 374,913 Shares = 0.68%

Non-beneficial - 150,273 Shares = 0.27%

Performance share scheme awards - 76,807 Shares = 0.14%

Deferred bonus plan awards - 5,619 Shares = 0.01%

Β 

Further information required by the Market Abuse Regulation in relation to these transactions is set out in the appendix below.

Β 

Enquiries:

R Webster

Company Secretary

Tel: +44 20 7802 8080

Β 

21 September 2020

Β 

APPENDIX

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

Lord Cayzer Will Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Sale of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.625

1,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

The Moorview Charitable Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Purchase of shares

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.625

1,000

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - XLON

Β 

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

P Bromage Settlement

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Appointment as a trustee of P Bromage Settlement resulting in James Cayzer-Colvin acquiring a non-beneficial interest in 16,237 ordinary shares

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

N/A

16,237

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

N/A

Β 

Β 

1

Β 

Details of the person discharging managerial responsibilities / person closely associated

Β 

a)

Β 

Name

Β 

Β 

ABT Cayzer Baronetcy Trust

2

Β 

Reason for the notification

Β 

a)

Β 

Position/status

Β 

Person closely associated with James Cayzer-Colvin, an Executive Director

Β 

b)

Β 

Initial notification /Amendment

Β 

Initial notification

3

Β 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

Β 

a)

Β 

Name

Β 

Caledonia Investments plc

b)

Β 

LEI

Β 

2138002FX1MYCA5ZZH32

4

Β 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

Β 

a)

Β 

Description of the financial instrument, type of instrument

Β 

Identification code

Β 

Ordinary 5p shares

Β 

Β 

GB0001639920

Β 

b)

Β 

Nature of the transaction

Β 

Β 

Appropriation of 3,529 ordinary shares between two of funds of the Trust

Β 

c)

Β 

Price(s) and volume(s)

Β 

Β 

Β 

Β 

Price(s)

Β 

Volume(s)

Β£25.50

3,529

d)

Β 

Aggregated information

Β 

- Aggregated volume

Β 

- Price

Β 

Β 

Β 

Β 

Β 

N/A (single transaction)

e)

Β 

Date of the transaction

Β 

Β 

16 September 2020

f)

Β 

Place of the transaction

Β 

London - outside a trading venue

Β 

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
DSHSEFFLFESSESU
Date   Source Headline
5th Jul 20247:00 amRNSTransaction in Own Shares
4th Jul 202411:29 amRNSNet Asset Value(s)
1st Jul 20247:00 amRNSTotal Voting Rights
1st Jul 20247:00 amRNSTransaction in Own Shares
24th Jun 20247:00 amRNSTransaction in Own Shares
13th Jun 20244:00 pmRNSAnnual Financial Report
7th Jun 20245:22 pmRNSDirector/PDMR Shareholding
6th Jun 20243:28 pmRNSDirector/PDMR Shareholding
6th Jun 20249:39 amRNSNet Asset Value(s)
30th May 20242:55 pmRNSDirector/PDMR Shareholding
21st May 20247:00 amRNSFinal Results
7th May 202410:40 amRNSNet Asset Value(s)
1st May 20247:00 amRNSTotal Voting Rights
1st May 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSNotice of annual results
22nd Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:30 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSUnaudited net asset value and portfolio update
2nd Apr 20247:01 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20243:19 pmRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 202410:32 amRNSDirector Declaration
6th Mar 20242:33 pmRNSNet Asset Value(s)
20th Feb 20245:02 pmRNSDirector/PDMR Shareholding
7th Feb 20241:31 pmRNSNet Asset Value(s)
30th Jan 20243:58 pmRNSDirector/PDMR Shareholding
19th Jan 20244:30 pmRNS2023 AGM results update statement
18th Jan 202411:56 amRNSDisposal
8th Jan 20247:00 amRNSUnaudited net asset value and portfolio update
7th Dec 20232:19 pmRNSNet Asset Value(s)
29th Nov 202311:49 amRNSDirector/PDMR Shareholding
27th Nov 20234:37 pmRNSDirector/PDMR Shareholding
21st Nov 20237:00 amRNSHalf-year Report
14th Nov 20233:28 pmRNSNotice of Half-Year Results
7th Nov 20237:00 amRNSNet Asset Value(s)
6th Oct 20237:00 amRNSUnaudited net asset value and portfolio update
28th Sep 20233:28 pmRNSDirector/PDMR Shareholding
25th Sep 202310:58 amRNSDirector/PDMR Shareholding
20th Sep 20239:56 amRNSDirector/PDMR Shareholding
8th Sep 20234:34 pmRNSDirector/PDMR Shareholding
7th Sep 20231:50 pmRNSDirector/PDMR Shareholding
5th Sep 20237:00 amRNSCaledonia signs agreement to sell 7IM
7th Aug 20237:00 amRNSNet Asset Value(s)
19th Jul 20235:53 pmRNSResult of AGM
7th Jul 202310:22 amRNSNet Asset Value and Portfolio Update
15th Jun 20234:01 pmRNSAnnual Financial Report
9th Jun 20235:27 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.